The trends driving ELRIG Drug Discovery 2022
Drug Discovery World
OCTOBER 4, 2022
Cell and gene therapies. There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . The trial will see Bayer using its subsidiary BrainVectis to investigate its gene therapy, BV-101 in the treatment for Huntington’s Disease (HD).
130 
Let's personalize your content